Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fortress Biotech has more than 25 development-stage programs and several marketed products, with clinical-stage candidates advancing in oncology, gene therapy, and rare diseases; notable recent milestones include FDA approvals in dermatology via its subsidiary Journey Medical Corporation and progressing novel assets in oncology and gene therapy[1][3][4][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fortress.